載入...
Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
Background. Anti-PD1/PDL1 immune checkpoint inhibitors (ICIs) showed promising results in breast cancer, and exploration of additional actionable immune checkpoints is ongoing. Inflammatory breast cancer (IBC) is an aggressive form of disease, the immune tumor microenvironment (TME) of which is poor...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8158040/ https://ncbi.nlm.nih.gov/pubmed/34104544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1929724 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|